U.S. adults with ASCVD report skipping meds due to costs

U.S. adults with ASCVD report skipping meds due to costs

(HealthDay)—More than 12 percent of patients with atherosclerotic cardiovascular disease (ASCVD) report nonadherence to medications due to costs, according to a study published online Nov. 25 in Circulation.

Rohan Khera, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues identified individuals aged ≥18 years with a reported history of ASCVD from the U.S. National Health Interview Survey (2013 to 2017). Participants who skipped doses to save money, took less to save money, or delayed filling a prescription to save in the preceding 12 months were considered to have experienced cost-related nonadherence (CRN).

The researchers found that a weighted 12.6 percent of the 14,279 surveyed individuals with ASCVD experienced CRN, including 8.6, 8.8, and 10.5 percent missing doses, taking lower than prescribed doses, and intentionally delaying a medication to save costs, respectively. Independent associations with CRN were seen for age <65 years, female sex, low family income, lack of health insurance, and high comorbidity burden; in these subgroups, more than one in five reported CRN. The odds of requesting low-cost medications and use of alternative, nonprescription therapies were increased 10.8-fold and 8.9-fold, respectively, among survey respondents with CRN versus those without CRN.

"Health policy interventions would need to urgently focus attention on targeting drug costs as an important avenue to improve adherence to medications and to reduce future needs of health care services," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further

Young CA survivors more often have cost-related nonadherence

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Circulation

Copyright © 2019 HealthDay. All rights reserved.

Citation: U.S. adults with ASCVD report skipping meds due to costs (2019, November 27) retrieved 31 July 2021 from https://medicalxpress.com/news/2019-11-adults-ascvd-meds-due.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments